Press releases

LinKinVax has the trust of world-class partners and investors.

Our last Press releases

May 4, 2022

LinKinVax appoints Dr Jiong Ma as independent board member 

LinKinVax's Logo
March 15, 2022

LinKinVax announces a collaboration with GTP Bioways for the development and production of its second-generation vaccine against SARS-CoV-2

LinKinVax's Logo
February 10, 2022

LINKINVAX raises €4.350 million in funding

To accelerate the developpement of its innovative vaccine platform
LinKinVax's Logo
February 3, 2022

LINKINVAX and INSERM TRANSFERT enter into an exclusive woldwild licensing agreement

Covering use of an innovative vaccine platform.
LinKinVax's Logo
June 21, 2021

Biotech start-up LinKinvax is created to accelerate the development, clinical trial and market access of a unique and innovative vaccine platform 

Biotech start-up LinKinvax is created to accelerate the development, clinical trial and market access of a unique and innovative vaccine platform
LinKinVax's Logo
May 26, 2021

LinKinVax-Labex VRI consortium secures 31 M€ in public funding to develop a booster vaccine against COVID-19

LinKinVax-Labex VRI consortium secures 31 M€ in public funding to develop a booster vaccine against COVID-19

SUBSCRIBE TO UPDATE !